rs2295715

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000465807.1(KAZALD1):​n.474G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.177 in 368,266 control chromosomes in the GnomAD database, including 6,595 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3628 hom., cov: 33)
Exomes 𝑓: 0.16 ( 2967 hom. )

Consequence

KAZALD1
ENST00000465807.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.22

Publications

3 publications found
Variant links:
Genes affected
KAZALD1 (HGNC:25460): (Kazal type serine peptidase inhibitor domain 1) This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. The protein contains an insulin growth factor-binding domain in its N-terminal region, a Kazal-type serine protease inhibitor and follistatin-like domain in its central region, and an immunoglobulin-like domain in its C-terminal region. Studies of the mouse ortholog suggest that this protein may function in bone development and bone regeneration. This gene is hypomethylated and over-expressed in high-grade glioma compared to low-grade glioma, and thus the hypomethylated gene may be associated with cell proliferation and the shorter survival of patients with high-grade glioma. It is also one of numerous genes found to be deleted in a novel 5.54 Mb interstitial deletion, which is associated with multiple congenital anomalies. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.293 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KAZALD1NR_135067.2 linkn.778G>A non_coding_transcript_exon_variant Exon 5 of 5
KAZALD1NR_135068.2 linkn.390G>A non_coding_transcript_exon_variant Exon 2 of 2
KAZALD1XR_246107.4 linkn.2945G>A non_coding_transcript_exon_variant Exon 6 of 6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KAZALD1ENST00000465807.1 linkn.474G>A non_coding_transcript_exon_variant Exon 2 of 2 1
KAZALD1ENST00000477267.1 linkn.677G>A non_coding_transcript_exon_variant Exon 5 of 5 5
ENSG00000288844ENST00000686265.2 linkn.547C>T non_coding_transcript_exon_variant Exon 1 of 1
ENSG00000288844ENST00000799115.1 linkn.142+62C>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.206
AC:
31310
AN:
152090
Hom.:
3621
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.298
Gnomad AMI
AF:
0.180
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.140
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.0842
Gnomad FIN
AF:
0.135
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.164
Gnomad OTH
AF:
0.217
GnomAD4 exome
AF:
0.157
AC:
33834
AN:
216058
Hom.:
2967
Cov.:
0
AF XY:
0.148
AC XY:
17747
AN XY:
119918
show subpopulations
African (AFR)
AF:
0.288
AC:
1638
AN:
5696
American (AMR)
AF:
0.238
AC:
3258
AN:
13714
Ashkenazi Jewish (ASJ)
AF:
0.138
AC:
687
AN:
4984
East Asian (EAS)
AF:
0.224
AC:
1857
AN:
8292
South Asian (SAS)
AF:
0.0917
AC:
4137
AN:
45130
European-Finnish (FIN)
AF:
0.142
AC:
1295
AN:
9116
Middle Eastern (MID)
AF:
0.184
AC:
413
AN:
2240
European-Non Finnish (NFE)
AF:
0.162
AC:
18860
AN:
116592
Other (OTH)
AF:
0.164
AC:
1689
AN:
10294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1389
2778
4166
5555
6944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.206
AC:
31342
AN:
152208
Hom.:
3628
Cov.:
33
AF XY:
0.203
AC XY:
15109
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.298
AC:
12370
AN:
41532
American (AMR)
AF:
0.238
AC:
3638
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.140
AC:
486
AN:
3468
East Asian (EAS)
AF:
0.230
AC:
1192
AN:
5174
South Asian (SAS)
AF:
0.0847
AC:
409
AN:
4830
European-Finnish (FIN)
AF:
0.135
AC:
1428
AN:
10588
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.164
AC:
11150
AN:
68004
Other (OTH)
AF:
0.216
AC:
456
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1286
2573
3859
5146
6432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.180
Hom.:
8830
Bravo
AF:
0.221
Asia WGS
AF:
0.151
AC:
524
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.17
DANN
Benign
0.90
PhyloP100
-3.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295715; hg19: chr10-102827228; API